Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search a test
Simple search

Simple search

*
(*) mandatory field


 

264 Result(s)

Result(s)sorted by
Speciality(ies)/objective(s)
(263)
(16)
(10)
(16)
(11)
(1)
Technique(s)
(4)
(1)
(29)
(1)
(1)
Purpose(s)
(1)
(3)
(261)
(1)
(23)
(154)
Quality management
(91)
(169)
Country(ies)
(1)
(4)
(9)
(10)
(1)
(17)
(1)
(3)
(2)
(1)
(18)
(58)
(5)
(2)
(1)
(11)
(27)
(1)
(1)
(8)
(1)
(5)
(5)
(2)
(1)
(44)
(2)
(5)
(2)
(16)
RESET
Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • Search for germinal mutations and big stature rearragements of PALB2, BRCA1 and BRCA2 genes
    • CLCC Institut Paoli Calmettes
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Accreditation
    • Search for mutations in BRCA1 and BRCA2 genes in breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CLCC François Baclesse
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • BASSE-NORMANDIE
    • CAEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CHU de Nantes - Institut de Biologie
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • NANTES
    • Accreditation
    • Diagnostic en biologie moléculaire des prédispositions au cancer du sein et de l'ovaire: analyse des gènes BRCA1 et BRCA2
    • Hôpitaux Universitaires de Genève HUG
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Search for somatic modifications in breast cancer (ERBB2 gene)
    • CLCC Institut Paoli Calmettes
    • Purpose(s) : Somatic genetics
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2 genes)
    • Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Paxis und Labor Dr. med Karl Mehnert
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2 (1100delC))
    • University Hospitals Leuven - Gasthuisberg
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Center for Medical Genetics Ghent
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
    • Molecular diagnosis of predisposition to breast cancer (CHEK2)
    • Center for Medical Genetics Ghent
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Erasme Hospital - ULB
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • St Mary's Hospital
    • Purpose(s) : Post-natal diagnosis, Somatic genetics, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Liverpool Women's NHS Foundation Trust
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Merseyside
    • LIVERPOOL
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA2 gene)
    • Southern General Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Lanarkshire
    • GLASGOW
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Birmingham Women's NHS Foundation Trust
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Mitteldeutscher Praxisverbund Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • Nottingham City Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Nottinghamshire
    • NOTTINGHAM
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes: Molecular diagnosis through sequencing and dosage analysis)
    • University Hospital of Wales
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • South Glamorgan
    • CARDIFF
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes: Mut. screening by CSCE, SNPlex and sequencing; dosage by MLPA)
    • Salisbury District Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, PALB2, RAD51C genes)
    • Medizinische Hochschule Hannover
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Accreditation
    • Antenatal and postnatal molecular diagnosis of hereditary breast and ovarian cancer syndrome (mutation scanning of selected exons and the entire coding region of BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera Universitaria Policlinico di Tor Vergata
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Universitätsklinikum Regensburg
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, PALB2, RAD51C, RAD51D, TP53 genes)
    • Zentrum für Humangenetik Mannheim
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • MANNHEIM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, MRE11A, PALB2, RAD51C)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRCA3, BRIP1, CHEK2, NBN, RAD51D genes)
    • Medizinisch Genetisches Zentrum München
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Charité - Universitätsmedizin Berlin (CVK)
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Institut de Pathologie et de Génétique - Gosselies
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • HAINAUT
    • GOSSELIES
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Medizinisches Versorgungszentrum Humane Genetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 -screen and known mutation- and BRCA2 - MLPA only - genes)
    • Aberdeen Royal Infirmary, Polwarth Building
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : MLPA based techniques
    • More information
    • UNITED KINGDOM
    • Grampian
    • ABERDEEN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • St George's University of London
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • VUmc - VU medisch centrum
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Noord-Holland
    • AMSTERDAM
    • Accreditation
    • Molecular diagnosis of Breast cancer. BRCA1, BRCA2 genes
    • Laboratorio de Análisis Dr. Echevarne
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1, BRCA2 and BRIP1 gene)
    • UMC Utrecht - Universitair Medisch Centrum Utrecht
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Utrecht
    • UTRECHT
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2 genes: Testing for known mutations in family members)
    • International Centre for Life
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • The Churchill Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Oxfordshire
    • OXFORD
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes by DNA sequencing and dosage)
    • Addenbrooke's Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CHEK2 and PTEN genes)
    • Institut für Humangenetik der Universität Göttingen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes: NGS Screening Panel)
    • Universität Würzburg - Biozentrum
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • GERMANY
    • Bayern
    • WÜRZBURG
    • Accreditation
    • Molecular diagnosis of Predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • Erasmus MC, Faculteitsgebouw
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Zuid-Holland
    • ROTTERDAM
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • LUMC - Leids Universitair Medisch Centrum
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Zuid-Holland
    • LEIDEN
    • Accreditation
    • Molecular diagnosis of Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • Radboudumc - Radboud universitair medisch centrum
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • UMCG - Universitair Medisch Centrum Groningen
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Groningen
    • GRONINGEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 & BRCA2 genes)
    • University Hospital of Antwerp - UZA- Centrum Medische Genetica - CMG
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN-EDEGEM
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • National Centre for Medical Genetics
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • IRELAND
    • County Dublin
    • DUBLIN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2)
    • Université Catholique de Louvain - UCL
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUXELLES
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Centogene AG
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C, RAD51D genes)
    • Universitätsklinikum Ulm
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (APEX: BRCA1, BRCA2, CHEK2, RAD51 and NBN genes ; total sequencing: BRCA1 and BRCA2 genes)
    • Asper Biotech Ltd.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, RAD51C genes)
    • Praxis für Humangenetik Freiburg
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHK2 genes)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
    • Diagenom GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • AZM - Academisch Ziekenhuis Maastricht
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Limburg
    • MAASTRICHT
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Sahlgrenska university hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWEDEN
    • Västra Götalandsregionen
    • GÖTEBORG
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (RAD51C gene: sequencing)
    • Diagenom GmbH
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Institut für Humangenetik am Universitätsklinikum Heidelberg
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA, RAD51C gene: sequencing)
    • GenteQ GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsmedizin Mainz
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Accreditation
    • Molecular diagnosis of RAD51C related diseases (RAD51C gene: sequencing and deletion analysis)
    • Kantonsspital Aargau
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • AARGAU
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 genes sequencing and deletion analysis)
    • Kantonsspital Aargau
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • AARGAU
    • Accreditation
    • Molecular diagnosis of PTEN-associated syndromes (PTEN gene)
    • Medizinische Universität Graz
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D genes)
    • Medizinische Universität Graz
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C, RAD51D genes)
    • Institut für Medizinische Genetik und angewandte Genomik Tübingen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • MVZ Fenner & Krasemann
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Schleswig-Holstein
    • LÜBECK
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Medizinische Universität Innsbruck
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BARD1, BRCA1, BRCA2, BRIP1, CHD1, CHEK2, MRE11A, MSH6, NBN, PALB2, PTEN, RAD50, RAD51C, STK11, TP53 genes: NGS Screening Panel)
    • Centogene AG
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Preimplantation molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2: by linkage and mutation analysis)
    • Institute for Women's Health
    • Purpose(s) : Pre-implantation diagnosis, Post-natal diagnosis, Somatic genetics, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of susceptibility to hereditary breast cancer (BRCA1, BRCA2 genes: exons including intron bounderies, sequencing and MLPA ; CHEK2 gene: exons 9 and 10 by MLPA)
    • Onkologicky ustav sv. Alzbety s.r.o.
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SLOVAKIA
    • Bratislavsky kraj
    • BRATISLAVA
    • Accreditation
    • Molecular Diagnosis of Breast/Ovarian Cancer (BRCA1 & BRCA2 genes)
    • Great Ormond Street Hospital for Children, York House
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Breast Cancer, familial (by Sanger sequencing- coding region BRCA1, BRCA2)
    • Trillium Health Partners- Credit Valley Site
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : Sanger sequencing
    • More information
    • CANADA
    • Ontario
    • MISSISSAUGA
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2 genes)
    • laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CDH1, RAD51C, PPM1D, TP53 genes: sequencing, MLPA)
    • Pränatalmedizin München
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (RAD51D, PALB2, PTEN genes)
    • CeGaT GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (CHEK2 gene / mutation (1100 from C); BRCA1, BRCA2, RAD51 genes / sequence analysis: entire coding region)
    • Reference Laboratory Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes: NGS Screening Panel)
    • Université Catholique de Louvain - UCL
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUXELLES
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universität Zürich
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • SCHLIEREN
    • Accreditation
    • Molecular Diagnosis of Hereditary Breast Cancer (sequence analysis, MLPA of BRCA1, BRCA2)
    • Children's Hospital of Eastern Ontario
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • CANADA
    • Ontario
    • OTTAWA
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, TP53 genes)
    • Labor Lademannbogen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular Diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1, BRCA2 sequencing, MLPA analysis)
    • Mount Sinai Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • CANADA
    • Ontario
    • TORONTO
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Labor PD Dr. Volkmann und Kollegen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • KARLSRUHE
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Institut für Humangenetik am Universitätsklinikum Jena
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Thüringen
    • JENA
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Synlab Lausanne
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWITZERLAND
    • Suisse Romande
    • LAUSANNE
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (comprehensive mutation screening of BRCA1 & BRCA2, including large rearrangements)
    • St James's University Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • Guy's Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, PALB2, RAD51C, RAD51D genes)
    • Institut für angewandte Humangenetik und Onkogenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • BAD STEBEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • IFLb Laboratoriumsmedizin Berlin GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular Diagnosis of Hereditary Breast Cancer (BRCA1 and BRCA2 analysis)
    • Kingston General Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CANADA
    • Ontario
    • KINGSTON
    • Accreditation
    • Molecular Diagnosis of Hereditary Breast Cancer (BRCA1 c.2071delA mutation)
    • Health Sciences Centre
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CANADA
    • Terre-Neuve-et-Labrador
    • ST. JOHN'S
    • Accreditation
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut Bergonié
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • CLCC Institut Curie
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut Gustave Roussy
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : NGS sequencing (except WES), MLPA based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • VILLEJUIF
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 ans BRCA2 genes)
    • IUCT Oncopole - CLCC Institut Claudius Regaud
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • MIDI-PYRENEES
    • TOULOUSE
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2)
    • CHU de Nancy - Hôpital de Brabois
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • LORRAINE
    • VANDOEUVRE-LÈS-NANCY
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C, PALB2 genes)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1, BRCA2 genes)
    • CLCC Jean Perrin
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : Sanger sequencing
    • More information
    • FRANCE
    • AUVERGNE
    • CLERMONT-FERRAND
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • CLCC Paul Strauss
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1, BRCA2, PALB2, TP53 genes)
    • Azienda Ospedaliera Istituti Ospitalieri di Cremona
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • CREMONA
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • Hospital de la Santa Creu i Sant Pau
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of predisposition to breast cancer (c-myc, HER-2)
    • Centro de Análisis Genéticos
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Aragón
    • ZARAGOZA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • CHUS - Complejo Hospitalario Universitario de Santiago
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Molecular diagnosis of predisposition to hereditary familial breast ovary cancer (BRCA1 and BRCA2 genes determined by targeted mutation analysis, sequence analysis of the entire coding region and MLPA)
    • Istituto Oncologico Veneto IRCCS
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
    • Technical procedure(s) : MLPA based techniques
    • More information
    • ITALY
    • VENETO
    • PADOVA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera Universitaria di Parma
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • PARMA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes / deletions and duplications)
    • Hospital Universitario Virgen del Rocío
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • More information
    • SPAIN
    • Andalucía
    • SEVILLA
    • Molecular diagnosis of familial breast cancer (BRCA1, BRCA2 genes)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, PALB2)
    • Oulu University Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FINLAND
    • Finland
    • OULU
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut Jean Godinot
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Hospital Universitario La Fe - Campanar
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes determined by sequence analysis of the entire coding region and MLPA)
    • Centro di Riferimento Oncologico
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : MLPA based techniques
    • More information
    • ITALY
    • FRIULI VENEZIA GIULIA
    • AVIANO
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CHRU de Montpellier - Hôpital Arnaud de Villeneuve
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Search for mutations in BRCA1 and BRCA2 genes in familial breast cancer
    • CHU de Lyon HCL - GH Edouard Herriot
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : Sanger sequencing
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes / DHPLC - sequencing - MLPA)
    • Hospital Universitario Miguel Servet
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Aragón
    • ZARAGOZA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • Faculdade de Medicina da Universidade de Lisboa
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2)
    • Odense University hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular diagnosis of predisposition to breast and/or ovarian cancer (BRCA1, BRCA2 and CHEK2 genes: sequencing and MLPA)
    • Leto Maternity Hospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Centro de Diagnóstico Biomédico - CDB
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of breast cancer (BRCA1 and BRCA2 genes)
    • IBGM - Instituto de Biología y Genética Molecular
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Castilla - León
    • VALLADOLID
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1 & BRCA2 genes)
    • Universitair Ziekenhuis Brussel - UZBrussel
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Molecular diagnosis of familial breast cancer. BRCA1, BRCA2 genes
    • DNA Data
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • IRCCS Ospedale San Raffaele
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of familial breast cancer
    • A.O.U. di Ferrara - Polo Chimico-Bio-Medico
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • FERRARA
    • Molecular diagnosis of proneness to familial breast cancer (BRCA1 and BRCA2 genes)
    • Laboratorio Genoma
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
    • Institut für Humangenetik des Universitätsklinikums Münster
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Karolinska University Hospital - Clinical Genetics
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1 and BRCA2 gene)
    • Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Noord-Holland
    • AMSTERDAM
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2)
    • Oslo University Hospital, Ullevaal
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • NORWAY
    • Østlandet
    • OSLO
    • Molecular diagnosis of predisposition to breast and prostate cancer (BRCA1 and BRCA2 genes)
    • Genetiks - Genetic diagnosis and research center
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Consorzio per la Genetica Molecolare Umana
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • MONZA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Clinical Center - University of Pécs
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • HUNGARY
    • Dél-Dunántúl
    • PECS
    • Preimplantation genetic diagnosis of the familial breast cancer. BRCA1 gene
    • Reprogenetics Spain S.A.
    • Purpose(s) : Pre-implantation diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of the familial breast cancer / breast and ovarian cancer (BRCA1, BRCA2 genes)
    • INGEMM - Instituto de Genética Médica y Molecular
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Pränatalzentrum Hamburg und Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of susceptibility to familial breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Oscar Lambret
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C, RAD51D genes)
    • Praxis für Humangenetik und Prävention
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 gene: target mutation analysis - single mutation (187delAG (BRCA1), 5385insC (BRCA1), 6174delT(BRCA2), c.156_157insAlu (BRCA2), sequence analysis of the entire coding region, and deletion/dluplication analysis by MLPA)
    • CGC Genetics / Centro de Genética Clínica
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : MLPA based techniques
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • NZOZ GENOMED
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes)
    • Biodiversity
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • BRESCIA
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 and RAD51C genes / complete sequencing; BRCA1, BRCA2 genes / MLPA)
    • IMEGEN - Instituto de Medicina Genómica
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 gene: 5382insC, 4153delA, 300T/G and 3819del5 mutations)
    • NZOZ Centrum Genetyki Medycznej Genesis
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Poznan
    • POZNAN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CHU de Reims - Hôpital Maison Blanche
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Institut für Klinische Genetik Bonn
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BONN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis für Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bremen
    • BREMEN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1 gene / exons 2, 3, 5, 8, 11, 13, 18, 20 and 23; BRCA2 gene / exons 2, 10, 11 and 23)
    • Lorgen G.P.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • SPAIN
    • Andalucía
    • ARMILLA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Praxis Dres. Gencik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene)
    • Przychodnia Fundacji Uniwersytetu Medycznego we Wroclawiu
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Wroclaw
    • WROCLAW
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Centro de Bioquímica y Genética Clínica
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Murcia
    • EL PALMAR
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2, PALB2, BRIP1, BARD1, RAD51C, PTEN, RAD51D genes)
    • Sistemas Genómicos S.L.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosisi of hereditary breast and ovarian cancer syndrome (PALB2 gene)
    • IMPPC - Instituto de Medicina Predictiva y Personalizada del Cáncer
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BADALONA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1 and BRCA2 genes; large deletions by MLPA kit P002 (BRCA1), kit P045 (BRCA2))
    • Hospital Universitario Donostia
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
    • bio.logis Zentrum für Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • MVZ Humangenetik Ulm
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes - CSCE/MLPA)
    • ICO L'Hospitalet
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PTEN, RAD51C, XRCC2 genes)
    • Klinikum Stuttgart - Standort Olgahospital
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, RAD51C, RAD51D, PALB2, PTEN)
    • Gemeinschaftspraxis für Humangenetik
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 genes)
    • Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • PIEMONTE
    • TORINO
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Biotecnologie Avanzate Srl
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Preimplantation genetic diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CME Barcelona
    • Purpose(s) : Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis für Humangenetik Dr. Lemmens
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • AACHEN
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Hospital Universitari General Vall d'Hebron
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of susceptibility hereditary to breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • IBGM - Instituto de Biología y Genética Molecular
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Castilla - León
    • VALLADOLID
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Hospital Clínico San Carlos
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing)
    • Institut für Humangenetik Wiesbaden
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hessen
    • WIESBADEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Institut für Humangenetik des Universitätsklinikums Münster
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (sequencing of BRCA1 and BRCA2 genes)
    • Onkologikoa
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Institut für Humangenetik am Universitätsklinikum Leipzig
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • MVZ wagnerstibbe für Laboratoriumsmedizin und Pathologie GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2, PALB2, PTEN genes / array-CGH)
    • Policlínica Gipuzkoa
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • Technical procedure(s) : Array based techniques
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • MEDGEN
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Consorci Sanitari de Terrassa
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • TERRASSA
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / sequencing, MLPA)
    • GenoClinics
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Andalucía
    • CAMPANILLAS
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (PALB2 gene / sequencing; genes BRCA1, BRCA2 / sequencing, MLPA)
    • Centro Inmunológico de Alicante (CIALAB)
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / sequencing; BRIP1, PALB2, RAD51C, BARD1 genes / HA-CSGE, sequencing; CHECK2 gene / dHPLC)
    • Universidad de Salamanca. Facultad de Medicina
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Castilla - León
    • SALAMANCA
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Medizinische Universität Wien
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • UKE - Universitätsklinikum Hamburg-Eppendorf
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of Hereditary breast cancer syndrome (RAD51 gene: sequencing of the entire coding region)
    • CGC Genetics / Centro de Genética Clínica
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of susceptibility to genetic gynecological tumor (BRCA1, BRCA2 genes / PCR, gene sequencing, MLPA, capillary electrophoresis)
    • IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : PCR based techniques, MLPA based techniques
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2 (110delC and exon9-10del), BRCA1, BRCA2, PALB2, RAD51C, RAD51D genes)
    • Institut für Humangenetik am Universitätsklinikum Freiburg
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / gene sequencing, MLPA)
    • Hospital del Mar
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Corporación Sanitaria Parc Taulí
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • SABADELL
    • Molecular Diagnosis of Chek2-Related Cancer Syndrome (1100delC mutation)
    • University of Alberta
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CANADA
    • Alberta
    • EDMONTON
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes: sequencing, MLPA)
    • Institut für Humangenetik der Universitätsmedizin Greifswald
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • GREIFSWALD
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Humangenetisches Institut am Universitätsklinikum Erlangen
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Bayern
    • ERLANGEN
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Centro Nacional de Investigaciones Oncológicas (CNIO)
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera "Infermi"
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • RIMINI
    • Molecular diagnosis of familial breast cancer (BRCA1, BRCA2)
    • Alborg Sygehus Nord
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • DENMARK
    • Jylland
    • ALBORG
    • Molecular diagnosis of predisposition to breast cancer. BRCA1, BRCA2 genes
    • Hospital Universitario Cruces - Osakidetza
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • País Vasco
    • BARAKALDO
    • Mutation screening for familial breast cancer (BRCA1 17q21.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • BIOGENOMICA
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of predisposition to breast cancer (BRCA1/BRCA2)
    • Análisis Genéticos ANCOR S.L.
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • ALICANTE
    • Molecular diagnosis of predisposition to breast cancer
    • Theagenion Cancer Centre of Thessaloniki
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GREECE
    • THESSALONIKI
    • THESSALONIKI
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • LabOrigo Diagnosztika
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • HUNGARY
    • Közép-Magyarország
    • BUDAPEST
    • Molecular diagnosis of breast cancer, familial (BRCA1, BRCA2 and PALB2 genes)
    • Azienda Ospedaliero Universitaria Careggi - NEUROFARBA
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • TOSCANA
    • FIRENZE
    • Molecular diagnosis of familial breast cancer
    • Istituto Nazionale per la Ricerca sul Cancro - IST
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LIGURIA
    • GENOVA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • GeneticLab
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ROMANIA
    • BUCURESTI
    • BUCURESTI
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Policlinico Universitario di Chieti
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • ABRUZZO
    • CHIETI
    • Molecular diagnosis of hereditary breast ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, PALB2, PTEN genes)
    • Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • TOSCANA
    • PISA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis Dr. med. Ulrike Beudt
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2)
    • Masaryk Memorial Cancer Institute
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Acibadem healthcare group
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Rudjer Boskovic Institute
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • CROATIA
    • CROATIA
    • ZAGREB
    • Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
    • Hadassah Ein Kerem - Hebrew University Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of Breast cancer (BRCA1, BRCA2, Mutation analysis)
    • Carmel Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Kaplan Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • REHOVOT
    • Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
    • The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis, PGD)
    • Sheba Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • RAMAT GAN
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Rabin Medical Center - Beilinson Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • PETAH TIKVA
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Assaf Harofeh Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • BEER YAAKOV
    • Molecular diagnosis of Cancer: breast , ovary (BRCA1, BRCA2, Mutation analysis, PGD)
    • Shaare Zedek Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of predisposition to familial breast and ovarian cancer (BRCA1 and BRCA2 mutation analyses)
    • IB Genetics OÜ
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ESTONIA
    • Tallinn
    • TALLINN
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Wolfson Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • HOLON
    • Molecular diagnosis of predisposition to familial breast cancer (complete BRCA1 and BRCA2 gene sequencing)
    • Université Saint-Joseph
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Emek Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • AFULA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 gene analysis by sequencing and MLPA)
    • Amplexa Genetics A/S
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular cytogenetics diagnosis of breast cancer by FISH analysis.
    • Hospital Universitario de Canarias
    • Purpose(s) : Somatic genetics
    • Specialty(ies) : Cytogenetics
    • Technical procedure(s) : FISH
    • More information
    • SPAIN
    • Canarias
    • SANTA CRUZ DE TENERIFE
    • Molecular diagnosis with germinal mutation analysis of breast and ovary cancer susceptibility syndrome (BRCA1 and BRCA2 genes)
    • A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • VARESE
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera San Giuseppe Moscati
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • CAMPANIA
    • AVELLINO
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1, BRCA2, CHEK2 and PALB2 complete gene sequencing; screening for BRCA1 and BRCA2 rearrangements by MLPA)
    • National center for scientific research Demokritos
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes: full sequencing and detection of known mutations)
    • DNA analysis
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • GREECE
    • IRAKLIO
    • HERAKLION
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • MELDOLA
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 full gene sequencing)
    • Pronto Diagnostics Ltd.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • TEL AVIV
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Vilnius University Hospital Santariskiu Klinikos
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • LITHUANIA
    • DZUKIJA
    • VILNIUS
    • Postnatal molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes: deletion/duplication analysis by MLPA)
    • National institute of legal medicine
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • Technical procedure(s) : MLPA based techniques
    • More information
    • ROMANIA
    • BUCURESTI
    • BUCURESTI
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • A.O. S. Andrea
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1, BRCA2 and PALB2 genes, and exon 11 in BRCA1 and BRCA2; BRCA1 gene / mutations in exons 2, 3, 5, 8, 11, 18, 20 and 23; BRCA2 gene / mutations in exons 2, 10, 11 and 23 - MLPA in BRCA1 and BRCA2 genes)
    • Laboratorio de Genética Clínica, S.L.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • Madrid
    • SAN SEBASTIÁN DE LOS REYES
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CLCC Georges-François Leclerc
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • INCLIVA
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Hospital San Pedro
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (sequencing of BRCA1 and BRCA2 genes)
    • Genyca Innova
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Madrid
    • MAJADAHONDA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Ospedale "R. Binaghi"
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • SARDEGNA
    • CAGLIARI
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • USI - Unione Sanitaria Internazionale
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and CHEK2 genes)
    • Szpital Uniwersytecki im. dr. Antoniego Jurasza
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Bydgoszcz
    • BYDGOSZCZ
    • Molecular diagnosis of cancer (NGS Cancer Panel)
    • ATG GenMed GmbH
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of predisposition to breast cancer (HER-2)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Complejo Hospitalario Universitario A Coruña
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Galicia
    • A CORUÑA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Laboratori Clodia Sas
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • VENETO
    • CHIOGGIA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene: seq/MLPA; BRCA2, BRIP1, CDH1, CHEK2, NBN, RAD50, RAD51C, PALB2, PTEN genes: sequencing)
    • ATG GenMed GmbH
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes: sequencing and MLPA)
    • G4L - Genomics For Life
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • AUSTRALIA
    • Queensland
    • BRISBANE
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Hospital Universitari de Sant Joan de Reus
    • Purpose(s) : Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • REUS
    • Mutation Screening for Breast and Ovarian Cancer (PTEN 10q23.31)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutation for Breast and Ovarian Cancer (PTEN 10q23.31)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation screening for familial breast cancer (BRCA2 13q13.1)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutation of familial breast cancer (BRCA2 13q13.1)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutation of familial breast cancer (BRCA1 13q21.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (STK11 19p13.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation screening for Breast and Ovarian Cancer (STK11 19p13.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (CHEK2 22q12.1)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (ATM 11q22.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation Screening for Breast and Ovarian Cancer (ATM 11q22.3)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation Screening for Breast and Ovarian Cancer (PALB2 16p12.2)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (PALB2 16p12.2)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (BRIP1 17q23.2)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation screening for Breast and Ovarian Cancer (BRIP1 17q23.2)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Mutation screening for Breast and Ovarian Cancer (BRAF 7q34)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutations for Breast and Ovarian Cancer (BRAF 7q34)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis, Somatic genetics
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular Diagnosis of Hereditary Breast/Ovarian Cancer (NGS BRCA1, BRCA2 genes)
    • London Health Sciences Centre
    • Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • CANADA
    • Ontario
    • LONDON
    • Hereditary Cancer Panel - Breast/Ovarian (19 genes)
    • London Health Sciences Centre
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • CANADA
    • Ontario
    • LONDON
    • Molecular Diagnosis of Hereditary Cancer Predisposition - Comprehensive NGS Panel (25 genes)
    • London Health Sciences Centre
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • CANADA
    • Ontario
    • LONDON
    • Molecular Diagnosis of High Penetrance Hereditary Cancer Predisposition - Comprehensive NGS Panel (16 genes)
    • London Health Sciences Centre
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : NGS sequencing (except WES)
    • More information
    • CANADA
    • Ontario
    • LONDON